BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 4, 2008
View Archived Issues
Lower diabetes rate seen with voclosporin compared to tacrolimus in renal transplant patients
Read More
Analyses reveal effects of sorafenib in hepatocellular carcinoma
Read More
Novel agents for bone disorders disclosed in recent Sungkyunkwan University patent
Read More
TorreyPines' NGX-267 meets primary endpoint in xerostomia phase II trial
Read More
Phase II study results reported for cardiovascular disease candidate VIA-2291
Read More
Questcor resubmits sNDA to FDA for H.P. Acthar Gel for infantile spasms
Read More
TransMolecular reaches SPA agreement with FDA for 131I-TM-601 phase III trial
Read More
Two pivotal HZT-501 phase III trials meet primary endpoints
Read More
NMRC submits revised IND to FDA to conduct Op RESUS trial of Biopure's Hemopure
Read More
Morphotek initiates phase II study of farletuzumab in platinum-resistant ovarian cancer
Read More
NPS initiates enrollment in phase III STEPS study of Gattex in short bowel syndrome
Read More
Mechanistically distinct drugs developed by PainCeptor, effective in pain models
Read More
New positive modulator of GABA-B receptors identified at Novartis
Read More
Recent Eisai and Scripps patents report novel antiinfective agents
Read More
Novel diagnostic agents imparted in recent patents
Read More
Twice-daily dosing of enzastaurin not feasible in glioma patients
Read More
Gene transfer of VEGF and HGF improves limb ischemia
Read More
HIV candidate VCH-286 safe, well tolerated in phase I study
Read More
Atorvastatin/fenofibrate tablet more effective than components in dyslipidemia
Read More
Azarga approved by EMEA for glaucoma or ocular hypertension
Read More
FDA grants orphan drug designation for antineoplaston treatment for gliomas
Read More
Geron initiates phase I vaccine candidate trial targeting telomerase
Read More
Genta receives FDA complete response letter for Genasense in CLL
Read More
Sucampo completed enrollment and initial dosing in two phase III trials of Amitiza in OBD
Read More
Eisai to initiate head-to-head clinical trial of Dacogen and Vidaza in MDS
Read More
FDA grants approval to PharmaEngine's IND for phase II study of PEP-02 in pancreatic cancer
Read More
Wyeth submits MAA in Europe for13-valent vaccine for pneumococcal disease
Read More
